Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RO1138452 (CAY10441) is a selective and orally bioavailable antagonist of prostacyclin receptor (pKi: 8.3). It antagonizes the carbaprostacyclin-induced activation of human neuroblastoma adenylate cyclase, blocking cyclic AMP accumulation in a dose-dependent manner. Likewise, it inhibits the binding of tritiated iloprost to rodent neuroblastoma cells with a Ki of about 1.5 nM. At levels between 2-20 mg/kg in rats, CAY10441 shows significant analgesic activity in standard antinociceptive assays [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 44.00 | |
2 mg | In stock | $ 63.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 155.00 | |
25 mg | In stock | $ 347.00 | |
50 mg | In stock | $ 597.00 | |
100 mg | In stock | $ 852.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 97.00 |
Description | RO1138452 (CAY10441) is a selective and orally bioavailable antagonist of prostacyclin receptor (pKi: 8.3). It antagonizes the carbaprostacyclin-induced activation of human neuroblastoma adenylate cyclase, blocking cyclic AMP accumulation in a dose-dependent manner. Likewise, it inhibits the binding of tritiated iloprost to rodent neuroblastoma cells with a Ki of about 1.5 nM. At levels between 2-20 mg/kg in rats, CAY10441 shows significant analgesic activity in standard antinociceptive assays [1]. |
Synonyms | CAY10441 |
Molecular Weight | 309.41 |
Formula | C19H23N3O |
CAS No. | 221529-58-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RO1138452 221529-58-4 GPCR/G Protein Immunology/Inflammation Others Prostaglandin Receptor RO-1138452 CAY 10441 CAY-10441 CAY10441 Inhibitor inhibit RO 1138452 inhibitor